40:40 Recruitment - celia@4040recruitment.co.uk

@4040rec.bsky.social

6 months ago

New CEO to slash 9,000 jobs at Novo Nordisk in restructure Novo Nordisk will cut 9,000 jobs across the company as it reallocates resources toward growth and innovation in the obesity and diabetes markets.

#NovoNordisk #restructure #MikeDoustdar #obesity #diabetes #chronicdiseases #restructuring #obesitydrugs #EliLilly #drugcompounders #greymarketproviders #staffcuts #Moderna #Bayer #MSD #Iovance #CSL #Lundbeck #MostFavouredNationsdrugpricingscheme #tariffs #patentexpirations
zurl.co/Imo5i

@jyves94.bsky.social

7 months ago

Iovance’s Amtagvi® (lifileucel) Receives Health Canada Approval for Advanced Melanoma First T cell therapy for a solid tumor cancer and first treatment option approved in Canada for advanced melanoma after anti-PD-1 and targeted therapy ...

⚡️ #Amtagvi d’ #Iovance reçoit l’approbation de Santé #Canada pour le traitement du #Mélanome R/R.

1ère thérapie par lymphocytes T pour un #Cancer à #TumeurSolide & 1ère option de traitement approuvée pour le mélanome après un traitement anti-1 & ciblé.

globenewswire.com/news-release...

pharmaphorum

@pharmaphorum.bsky.social

8 months ago

Iovance cuts staff on slower cell therapy sales growth Iovance will slash 19% of its headcount in a restructuring that follows slower-than-expected sales growth for melanoma cell therapy Amtagvi

#Iovance will slash 19% of its headcount in a restructuring that follows slower-than-expected sales growth for melanoma cell therapy Amtagvi.

pharmaphorum.com/news/iovance...

Thiard News@F4F

@newsen.bsky.social

9 months ago

Investors in Iovance Biotherapeutics Have a Chance to Lead a Securities Fraud Lawsuit Investors who faced losses in Iovance Biotherapeutics, Inc. now have a chance to step forward and lead a potential class action lawsuit for securities fraud against the company.

Investors in Iovance Biotherapeutics Have a Chance to Lead a Securities Fraud Lawsuit #USA #Securities_Fraud #Investor_Rights #Bensalem #Iovance

Thiard News@F4F

@newsen.bsky.social

9 months ago

Levi & Korsinsky Alerts Iovance Biotherapeutics Investors on Class Action Lawsuit and Important Deadlines Levi & Korsinsky, LLP has informed investors of Iovance Biotherapeutics, Inc. about a class action lawsuit, emphasizing a crucial deadline for potential claimants.

Levi & Korsinsky Alerts Iovance Biotherapeutics Investors on Class Action Lawsuit and Important Deadlines #United_States #New_York #Class_Action #Levi_&_Korsinsky #Iovance

Thiard News@F4F

@newsen.bsky.social

9 months ago

Class Action Lawsuit Filed Against Iovance Biotherapeutics, Investors Alerted Investors of Iovance Biotherapeutics are urged to join a class action lawsuit following significant revenue drops and alleged securities fraud. Key deadlines are approaching.

Class Action Lawsuit Filed Against Iovance Biotherapeutics, Investors Alerted #USA #New_York #Securities_Fraud #Pomerantz #Iovance

Thiard News@F4F

@newsen.bsky.social

9 months ago

Investors of Iovance Biotherapeutics Seek Legal Action for Securities Fraud Iovance Biotherapeutics investors who suffered losses now have the chance to participate in a securities fraud lawsuit. Here's how you can join.

Investors of Iovance Biotherapeutics Seek Legal Action for Securities Fraud #USA #Los_Angeles #Securities_Fraud #Frank_R._Cruz #Iovance

Thiard News@F4F

@newsen.bsky.social

9 months ago

Investors Can Lead Class Action Against Iovance Biotherapeutics for Securities Fraud Iovance Biotherapeutics faces a class action lawsuit for alleged securities fraud. The Schall Law Firm seeks investors to join the case and recover losses.

Investors Can Lead Class Action Against Iovance Biotherapeutics for Securities Fraud #USA #Los_Angeles #Schall_Law_Firm #Securities_Fraud #Iovance

Thiard News@F4F

@newsen.bsky.social

9 months ago

Iovance Biotherapeutics Inc. Shareholders: Your Rights Explained in the Ongoing Lawsuit Discover your legal rights as a shareholder of Iovance Biotherapeutics in the ongoing class action lawsuit led by the DJS Law Group.

Iovance Biotherapeutics Inc. Shareholders: Your Rights Explained in the Ongoing Lawsuit #USA #securities_lawsuit #DJS_Law_Group #Eastchester #Iovance

Thiard News@F4F

@newsen.bsky.social

9 months ago

IOVA Shareholders Urged to Take Action in Class Action Against Iovance Biotherapeutics The DJS Law Group is calling on IOVA shareholders to join a class action lawsuit regarding securities law violations potentially affecting investor rights.

IOVA Shareholders Urged to Take Action in Class Action Against Iovance Biotherapeutics #USA #DJS_Law_Group #Eastchester #IOVA #Iovance

Thiard News@F4F

@newsen.bsky.social

9 months ago

Lead the Charge: Investors Have a Chance to Join Iovance Biotherapeutics Lawsuit Investors of Iovance Biotherapeutics, Inc. can join a key securities fraud lawsuit. Don't miss the July 14, 2025 deadline!

Lead the Charge: Investors Have a Chance to Join Iovance Biotherapeutics Lawsuit #USA #New_York #Securities_Fraud #Rosen_Law_Firm #Iovance

Thiard News@F4F

@newsen.bsky.social

9 months ago

Join the Class Action Against Iovance Biotherapeutics: Act Before July 14, 2025 Attention Iovance Biotherapeutics shareholders: A class action lawsuit is underway. Join now to protect your rights before the July 14, 2025, deadline.

Join the Class Action Against Iovance Biotherapeutics: Act Before July 14, 2025 #USA #New_York #Class_Action #Gross_Law_Firm #Iovance

Thiard News@F4F

@newsen.bsky.social

9 months ago

Iovance Biotherapeutics Investors Find Hope in New Lawsuit Opportunity Against Securities Fraud Investors who lost money in Iovance Biotherapeutics, Inc. can now lead a securities fraud class action lawsuit, according to a legal firm announcement. Act by July 14, 2025.

Iovance Biotherapeutics Investors Find Hope in New Lawsuit Opportunity Against Securities Fraud #United_States #Los_Angeles #Frank_R._Cruz #Iovance_Biotherapeutics #Iovance

Thiard News@F4F

@newsen.bsky.social

9 months ago

Levi & Korsinsky Alerts Iovance Investors on Lead Plaintiff Deadline for Class Action Lawsuit Levi & Korsinsky reminds shareholders of Iovance Biotherapeutics about the deadline for lead plaintiff requests in a class action lawsuit related to securities fraud.

Levi & Korsinsky Alerts Iovance Investors on Lead Plaintiff Deadline for Class Action Lawsuit #USA #New_York #Class_Action #Securities_Fraud #Iovance

Thiard News@F4F

@newsen.bsky.social

9 months ago

Investors of Iovance Biotherapeutics Urged to Join Securities Fraud Class Action Investors holding Iovance Biotherapeutics securities from May 2024 to 2025 are reminded to join a class-action lawsuit against the company before the deadline.

Investors of Iovance Biotherapeutics Urged to Join Securities Fraud Class Action #USA #New_York #Securities_Fraud #Rosen_Law_Firm #Iovance

Thiard News@F4F

@newsen.bsky.social

9 months ago

Join the Class Action Against Iovance Biotherapeutics Before the Deadline: Important Information for Investors Attention Iovance Biotherapeutics investors: Join the class action lawsuit by July 14, 2025. Shareholders urged to register for updates.

Join the Class Action Against Iovance Biotherapeutics Before the Deadline: Important Information for Investors #United_States #New_York #Class_Action #Gross_Law_Firm #Iovance

Thiard News@F4F

@newsen.bsky.social

9 months ago

Investor Rights and Class Action Against Iovance Biotherapeutics, Inc. Explained This article explores the class action lawsuit against Iovance Biotherapeutics, highlighting shareholders' rights and legal recourse available to them.

Investor Rights and Class Action Against Iovance Biotherapeutics, Inc. Explained #United_States #Los_Angeles #DJS_Law_Group #IOVA #Iovance

Thiard News@F4F

@newsen.bsky.social

9 months ago

Iovance Biotherapeutics Investors Should Consider Joining Class Action Lawsuit Led by the Schall Law Firm Investors in Iovance Biotherapeutics, Inc. are being encouraged to join a class action lawsuit led by the Schall Law Firm for alleged securities fraud. Know your rights.

Iovance Biotherapeutics Investors Should Consider Joining Class Action Lawsuit Led by the Schall Law Firm #United_States #Los_Angeles #Securities_Fraud #Schall_Law #Iovance

Thiard News@F4F

@newsen.bsky.social

9 months ago

Iovance Biotherapeutics Faces Securities Law Violation Lawsuit - Key Details Inside Iovance Biotherapeutics is currently facing a class action lawsuit for securities law violations. Investors impacted during the specified period are urged to get in touch with Levi & Korsinsky for guidance.

Iovance Biotherapeutics Faces Securities Law Violation Lawsuit - Key Details Inside #United_States #New_York #Levi_&_Korsinsky #Securities #Iovance

Thiard News@F4F

@newsen.bsky.social

9 months ago

Investors Rally Around Iovance Biotherapeutics Lawsuit Opportunity Investors of Iovance Biotherapeutics who faced losses may join a class action lawsuit led by The Schall Law Firm, focusing on alleged securities fraud.

Investors Rally Around Iovance Biotherapeutics Lawsuit Opportunity #USA #Los_Angeles #Schall_Law_Firm #Securities_Fraud #Iovance

Thiard News@F4F

@newsen.bsky.social

10 months ago

Iovance Biotherapeutics Shareholders Invited to Lead Class Action Lawsuit Iovance Biotherapeutics faces a class action lawsuit for alleged securities law violations. Shareholders are encouraged to contact DJS Law Group to discuss their rights.

Iovance Biotherapeutics Shareholders Invited to Lead Class Action Lawsuit #United_States #Class_Action #DJS_Law_Group #Eastchester #Iovance

Thiard News@F4F

@newsen.bsky.social

10 months ago

Investors of Iovance Biotherapeutics May Lead Class Action Against Securities Fraud Claims Investors suffering over $100,000 losses with Iovance Biotherapeutics are encouraged to engage with Faruqi & Faruqi, LLP, for potential action.

Investors of Iovance Biotherapeutics May Lead Class Action Against Securities Fraud Claims #USA #New_York #Securities_Fraud #Faruqi_&_Faruqi #Iovance

Thiard News@F4F

@newsen.bsky.social

10 months ago

Iovance Biotherapeutics Faces Class Action Lawsuit Over Securities Fraud Allegations Investors in Iovance Biotherapeutics, Inc. are urged to reach out to Levi & Korsinsky by July 14, 2025, to explore their rights following a class action lawsuit.

Iovance Biotherapeutics Faces Class Action Lawsuit Over Securities Fraud Allegations #United_States #New_York #Levi_&_Korsinsky #Securities_Fraud #Iovance

Profit Trading USA

@profittradingusa.bsky.social

10 months ago

Iovance stock plummets after lowered full-year guidance, missed analyst expectations for Amtagvi - Endpoints News Iovance stock plummets after lowered full-year guidance, missed analyst expectations for Amtagvi  Endpoints News

Click Subscribe #Iovance #stockmarket #investing #finance #stocks

Profit Trading USA

@profittradingusa.bsky.social

10 months ago

Click Subscribe #Iovance #StockMarket #Investing #Finance #Q1Earnings